A univariate and multivariate analysis of variables predicting 30-day mortality
| Variables | Univariate analysis | Multivariate analysis | |||
| Mortality within 30 days (n=81) Mean (SD) | Survival beyond 30 days (n=307) Mean (SD) | P value | OR (95% CI) | P value | |
| Age | 55.9 (12.5) | 56.9 (13.6) | 0.564 | ||
| Sex (male) N (%) | 58 (71.6) | 204 (66.4) | 0.379 | ||
| Sodium (mmol/L) | 131.6 (8.6) | 134.5 (6.8) | 0.001 | 0.98 (0.94 to 1.01) | 0.181 |
| Creatinine (µmol/L) | 143.3 (121.1) | 98.3 (92.0) | <0.001 | 1.00 (1.00 to 1.00) | 0.096 |
| Bilirubin (µmol/L) | 194.1 (179.6) | 100.67 (135.1) | <0.001 | 1.00 (1.00 to 1.00) | 0.011 |
| ALT (U/L) | 99.0 (172.9) | 60.2 (108.8) | 0.013 | 1.00 (1.00 to 1.01) | 0.573 |
| AST (U/L) | 197.1 (305.2) | 111.8 (166.4) | <0.001 | 1.00 (1.00 to 1.00) | 0.465 |
| Albumin (g/L) | 28.3 (5.1) | 30.2 (5.8) | 0.007 | 0.96 (0.91 to 1.01) | 0.076 |
| INR | 1.9 (1.0) | 1.5 (0.6) | <0.001 | 1.38 (0.95 to 2.00) | 0.095 |
| Platelets (×109/L) | 127.5 (80.7) | 127.0 (71.8) | 0.956 | ||
| WCC (×109/L) | 12.4 (7.5) | 8.8 (7.5) | <0.001 | 1.02 (0.99 to 1.04) | 0.209 |
| CRP (mg/L) | 57.3 (57.4) | 30.3 (39.1) | <0.001 | 1.01 (1.00 to 1.01) | 0.017 |
| Ascites N (%) | 66 (81.5) | 217 (70.7) | 0.052 | ||
| Hepatic encephalopathy N(%) | 48 (59.3) | 96 (31.3) | <0.001 | 1.70 (1.00 to 2.87) | 0.049 |
| GI bleeding N (%) | 36 (44.4) | 111 (36.2) | 0.172 | ||
| Infection N (%) | 57 (70.4) | 125 (40.7) | 0.007 | 1.75 (0.97 to 3.15) | 0.063 |
| SBP N (%) | 20 (24.7) | 26 (8.5) | <0.001 | 1.14 (0.55 to 2.37) | 0.725 |
| First admission during COVID-19 time period N (%) | 30 (37.0) | 112 (36.5) | 0.927 | ||
| Transferred from another centre N (%) | 35 (43.2) | 110 (35.8) | 0.193 | ||
Values that are statistically significant are displayed in bold.
CRP, C reactive protein; GI, gastrointestinal; SBP, spontaneous bacterial peritonitis; WCC, white cell count.